AIkido Pharma (AIKI) Competitors $5.73 -0.01 (-0.17%) As of 08/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. LUNA, DKDCA, SERA, AVTX, TCRX, MBOT, FONR, ENTX, IMUX, and SRZNShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Luna Innovations (LUNA), Data Knights Acquisition (DKDCA), Sera Prognostics (SERA), Avalo Therapeutics (AVTX), TScan Therapeutics (TCRX), Microbot Medical (MBOT), Fonar (FONR), Entera Bio (ENTX), Immunic (IMUX), and Surrozen (SRZN). AIkido Pharma vs. Its Competitors Luna Innovations Data Knights Acquisition Sera Prognostics Avalo Therapeutics TScan Therapeutics Microbot Medical Fonar Entera Bio Immunic Surrozen Luna Innovations (NASDAQ:LUNA) and AIkido Pharma (NASDAQ:AIKI) are both small-cap commercial physical research industry companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership. Which has better earnings and valuation, LUNA or AIKI? Luna Innovations has higher revenue and earnings than AIkido Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLuna Innovations$116.61M0.26$9.28MN/AN/AAIkido PharmaN/AN/A-$7.17M-$3.88-1.48 Do institutionals & insiders hold more shares of LUNA or AIKI? 87.5% of Luna Innovations shares are held by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are held by institutional investors. 7.6% of Luna Innovations shares are held by company insiders. Comparatively, 8.6% of AIkido Pharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, LUNA or AIKI? Luna Innovations has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Does the media prefer LUNA or AIKI? In the previous week, Luna Innovations' average media sentiment score of 0.00 equaled AIkido Pharma'saverage media sentiment score. Company Overall Sentiment Luna Innovations Neutral AIkido Pharma Neutral Is LUNA or AIKI more profitable? Luna Innovations' return on equity of 0.00% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Luna InnovationsN/A N/A N/A AIkido Pharma N/A -18.21%-16.94% SummaryLuna Innovations beats AIkido Pharma on 6 of the 7 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIKI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.43M$24.14M$5.45B$9.62BDividend YieldN/AN/A4.61%4.14%P/E Ratio-1.48N/A29.9024.86Price / SalesN/A0.26449.4298.78Price / CashN/A57.2336.4258.36Price / Book0.300.308.185.65Net Income-$7.17M-$525K$3.26B$265.99M7 Day Performance27.33%4.95%6.13%5.07%1 Month Performance13.69%1.84%0.94%1.43%1 Year Performance262.66%48.62%28.86%22.53% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$5.73-0.2%N/A+263.6%$31.43MN/A-1.484High Trading VolumeLUNALuna Innovations0.2706 of 5 stars$0.95+35.7%N/A-65.9%$32.26M$116.61M0.00390Gap UpDKDCAData Knights AcquisitionN/A$0.48+0.7%N/A-49.5%$2.49MN/A-2.542High Trading VolumeSERASera Prognostics0.6336 of 5 stars$2.45-5.4%N/A-66.5%$97.57M$80K0.00120News CoverageEarnings ReportAnalyst DowngradeHigh Trading VolumeAVTXAvalo Therapeutics2.6804 of 5 stars$8.20-8.6%$30.00+265.9%-17.5%$97.12M$440K0.0040News CoverageEarnings ReportGap UpHigh Trading VolumeTCRXTScan Therapeutics3.7043 of 5 stars$1.75+2.3%$7.80+345.7%-72.9%$96.77M$2.82M0.00100Upcoming EarningsMBOTMicrobot Medical1.6497 of 5 stars$2.88+8.7%$9.00+212.5%+227.6%$96.40MN/A-4.4320Upcoming EarningsGap UpFONRFonar1.4882 of 5 stars$15.73+2.4%N/A-8.7%$95.29M$102.88M12.58480ENTXEntera Bio2.768 of 5 stars$2.02-2.9%$10.00+395.0%+13.5%$94.54M$180K0.0020News CoverageEarnings ReportGap UpIMUXImmunic2.6941 of 5 stars$0.98+0.3%$7.50+664.4%-34.9%$93.73MN/A0.0070News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpSRZNSurrozen2.7203 of 5 stars$10.40-4.9%$38.50+270.2%+34.6%$93.68M$10.65M0.0080News CoverageUpcoming Earnings Related Companies and Tools Related Companies Luna Innovations Alternatives Data Knights Acquisition Alternatives Sera Prognostics Alternatives Avalo Therapeutics Alternatives TScan Therapeutics Alternatives Microbot Medical Alternatives Fonar Alternatives Entera Bio Alternatives Immunic Alternatives Surrozen Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
